Pharmacy Podcast Network

PRISM Enters the Chat & LTC Insurance in Pharmacy | TWIRx RxRated Version    📅 Release Date: October 17, 2025 🎧 Produced by: Pharmacy Podcast Network 🧠 Segment 1: Innovation Spotlight – OvaryIT & the PRISM Platform Guests: Mary Kucek, CEO & Founder, OvaryIT Devin Bustin, MD, Chief Medical Officer, OvaryIT The future of pharmacy practice management has arrived. Mary Kucek and Dr. Devin Bustin introduce PRISM, the first fully integrated EHR system built exclusively for community pharmacists. PRISM streamlines clinical workflows, ensures compliance, and empowers pharmacists to expand services—from point-of-care testing and chronic disease management to vaccinations and remote patient monitoring. This segment unpacks how PRISM helps protect your license, improve patient outcomes, and grow your business with technology designed by pharmacists, for pharmacists. 💡 Segment 2: Financial Literacy & Long-Term Care Planning with Michael Banner Guest: Michael Banner, Founder & Host, 62WhoKnew Podcast Michael Banner brings decades of expertise across the mortgage, financial, and LTC insurance industries to discuss how pharmacists and healthcare professionals can better educate aging populations about financial security and care planning. Learn why he built 62WhoKnew as the ultimate referral source for retirement preparation and hear insights on integrating long-term care insurance discussions into pharmacy-based clinical care models. 💰 Segment 3: The 8th Annual Pharmacy Profit Summit Guest: Lisa Faast, PharmD, CEO, DiversifyRx Get ready for the Pharmacy Profit Summit 2025—happening March 26–27 in Dallas, TX. Dr. Lisa Faast shares what’s new for the 8th annual event, including innovative strategies to boost profitability, reduce overhead, and future-proof independent pharmacies. Hear what attendees can expect from this year’s sessions, networking, and vendor showcases that make the Summit a can’t-miss event for forward-thinking pharmacy owners. 💬 Segment 4: TWIRx RxRated Roundtable – Trust, Transparency, and Controversy in Healthcare Hosts: Robbie Abasi, PharmD Sam Ilona, PharmD Xavier Hill, PharmD, BCPS, BCGP The RatedRx Podcast team joins TWIRx for an unfiltered discussion on trust in healthcare, media narratives, and the controversy shaping public perception of the profession. From patient misinformation to provider burnout, this roundtable doesn’t hold back—bringing authenticity and humor to the realities of modern pharmacy. 🔊 Episode Summary This week on This Week in Pharmacy, innovation meets impact. From next-generation EHR technology with PRISM to retirement readiness and LTC awareness with Michael Banner, plus a spotlight on profit-driven growth with DiversifyRx’s Lisa Faast—this episode covers the clinical, business, and human sides of pharmacy. We wrap it all up with RatedRx, where pharmacists talk real about the issues shaping trust in healthcare today.

The Pharmacy Podcast Network is back on the show floor at the NASP Annual Expo, live in Denver, CO! Thank you JB Consulting for Sponsoring this episode! On part one of this series we interview: Christine Tang Wilson with Lumicera Health Services Amanda Awe with VLP Christopher Corsi, CEO, CassianRx Hayley Burgess with Inovalon Eric Robertson with DoseSpot Harry Travis with The Travis Group LLC Ethan Wynn with Sphinx Strategies Heidi Polleck with Outcomes

In part two of our exclusive three-part series, host Todd Eury continues the conversation live from the 2025 FrameworkLTC Innovation Conference. Hear from LTC pharmacy professionals, trusted partners, and SoftWriters experts as they share their experiences, key takeaways, and perspectives on the evolving world of long-term care pharmacy.

I had the honor of interviewing a like-hearted soul whom I deeply respect and admire, around the topic of transmuting our grief, rage + fear about the wider big picture of the world. For such a heavy topic, I came out of it inspired to connect deeper with nature, and grateful for the gift of life. ​Gwyneth Jones guides individuals through the emotional and spiritual journey of confronting the state of our world, drawing upon a diverse toolkit that includes ecotherapy, emotional intelligence, mindfulness, and positive psychology. She is a certified coach and Work that Reconnects facilitator, as well as a writer and podcast host on topics relating to our psychological and spiritual response to collapse, ecopsychology and our connection to the web of life, and effective changemaking. Connect with Gwyneth via: Email: gwynethajones86@gmail.com  Website: Gwyneth Jones Coach & Connector FB: Gwyneth Jones - Coach & Connector IG: @gwynethjones.connectioncoach Linked In: Gwyneth Jones Get the epic “Staying Grounded in Times of Crisis” ebook, available as a free download from her website.  And check out our upcoming livestream about herbalism as a form of resilience on September 25th, and our interactive workshop on this topic on October 23rd! We look forward to building community and sharing the tools that our ancestors worked with and are still relevant today. Visit https://marinabuksov.com for more holistic content. Music from https://www.purple-planet.com.  Disclaimer: Statements herein have not been evaluated by the Food and Drug Administration. Products listed are not intended to diagnose, treat, cure, or prevent any diseases.

Independent pharmacy owners face unique challenges. On this episode of Counter Talk™ Podcast, host Jason Callori speaks with Jason Kizer, PharmD, owner of Kizer Pharmacy, about revitalizing your pharmacy's culture.                                                                                                                                                                                                                                                                                        Discover strategies to boost staff morale, empower your team to provide exceptional patient care, and build a trusted healthcare destination. Jason shares his journey of pharmacy ownership and how he fostered a culture shift within his team. 

🎙️ Featured Guests: John Covello – Independent Pharmacy Cooperative (IPC) Garth Reynolds – Illinois Pharmacists Association (IPhA) Illinois pharmacy owners, this episode is for you. With the passage of HB 1697, a $70 million lifeline is now available to support independent pharmacies across the state—but the clock is ticking. The October 31st deadline is critical. Covello and Reynolds break down: The Critical Access Pharmacy Fund – how it strengthens local pharmacies. The DECO program – what it means for reimbursement. Patient Self-Management Programs (PSMP) – driving patient care and outcomes. The one-minute attestation that unlocks enhanced Medicaid dispensing fees. If you’re a pharmacy owner in Illinois, this could be the most important 30 minutes you’ll spend this month. 🎶 Special Feature: Mary Kutter This week, TWIRx also spotlights Mary Kutter, a rising country singer-songwriter from Kentucky. Known for her gritty, truthful storytelling, Kutter’s music explores themes of family, small-town struggles, and the opioid crisis. With viral songs like “Devil’s Money” and “The Devil Wore a Lab Coat”, plus songwriting credits for artists like Bailey Zimmerman, Kutter’s voice is shaping the soundtrack of rural America. Signed with Reservoir Media, she brings a raw perspective on how music can confront issues like addiction while honoring her Kentucky roots. 💡 Episode Highlights: The $70M opportunity Illinois pharmacies can’t afford to miss. How independent pharmacies can secure financial stability through HB 1697. Why Medicaid fee enhancements could change the game. Mary Kutter on blending country grit with the reality of the opioid epidemic. 📌 Don’t miss this episode of This Week in Pharmacy. It’s where policy, patient care, and culture intersect.

The host has been a community pharmacy advocate for 22 years. Always looking for ways to help community pharmacies be more profitable. The guest is an experienced Pharmacist with a demonstrated history of working in the pharmaceutical industry. Skilled in Diabetes, Pharmacy Practice, Community Pharmacy, and Clinical Pharmacology.

This podcast is sponsored by YARAL Pharma.  In this episode, we are focusing on the management of hypothyroidism -- a treatable, but not curable condition – and will explore unique challenges for patients with hypothyroidism in long-term care – from tolerability and formulation considerations to consistent dosing and patient needs. Dr. Tamara Ruggles is not affiliated with YARAL Pharma. All views and opinions regarding hypothyroidism are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. IMPORTANT SAFETY INFORMATION for levothyroxine sodium capsules INDICATION AND USAGE Levothyroxine sodium capsules are L-thyroxine (T4) indicated for adults and pediatric patients 6 years and older with: Hypothyroidism - As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression - As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well differentiated thyroid cancer Limitations of Use: Levothyroxine sodium capsules are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with Levothyroxine sodium capsules may induce hyperthyroidism. Levothyroxine sodium capsules are not indicated for treatment of transient hypothyroidism during the recovery phase of subacute thyroiditis WARNING: NOT FOR THE TREATMENT OF OBESITY OR FOR WEIGHT LOSS Thyroid hormones, including levothyroxine sodium capsules, either alone or with other therapeutic agents, should not be used for the treatment of obesity or for weight loss. In euthyroid patients, doses within the range of daily hormonal requirements are ineffective for weight reduction. Larger doses may produce serious or even life-threatening manifestations of toxicity, particularly when given in association with sympathomimetic amines such as those used for their anorectic effects. Contraindications Uncorrected adrenal insufficiency Warnings and Precautions Cardiac adverse reactions in the elderly and in patients with underlying cardiovascular disease: Initiate Levothyroxine sodium capsules at less than the full replacement dose because of the increased risk of cardiac adverse reactions, including atrial fibrillation Myxedema coma: Do not use oral thyroid hormone drug products to treat myxedema coma Acute adrenal crisis in patients with concomitant adrenal insufficiency: Treat with replacement glucocorticoids prior to initiation of levothyroxine sodium capsules treatment Prevention of hyperthyroidism or incomplete treatment of hypothyroidism: Proper dose titration and careful monitoring is critical to prevent the persistence of hypothyroidism or the development of hyperthyroidism Worsening of diabetic control: Therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. Carefully monitor glycemic control after starting, changing, or discontinuing thyroid hormone therapy Decreased bone mineral density associated with thyroid hormone over-replacement: Over-replacement can increase bone reabsorption and decrease bone mineral density. Give the lowest effective dose Adverse Reactions Common adverse reactions with levothyroxine therapy are primarily those of hyperthyroidism due to therapeutic overdosage. They include the following: General: fatigue, increased appetite, weight loss, heat intolerance, fever, excessive sweating Central Nervous System: headache, hyperactivity, nervousness, anxiety, irritability, emotional ability, insomnia Musculoskeletal: tremors, muscle weakness Cardiovascular: palpitations, tachycardia, arrythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction, cardiac arrest Respiratory: dyspnea Gastrointestinal (GI): diarrhea, vomiting, abdominal cramps, elevations in liver function tests Dermatologic: hair loss, flushing Endocrine: decreased bone mineral density Reproductive: menstrual irregularities, impaired fertility Adverse Reactions in Children Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving levothyroxine therapy. Overtreatment may result in craniosynostosis in infants and premature closure of the epiphyses in children with resultant compromised adult height. Seizures have been reported rarely with the institution of levothyroxine therapy. Hypersensitivity Reactions Hypersensitivity reactions to inactive ingredients (in this product or other levothyroxine products) have occurred in patients treated with thyroid hormone products. These include urticaria, pruritis, skin rash, flushing, angioedema, various GI symptoms (abdominal pain, nausea, vomiting and diarrhea), fever, arthralgia, serum sickness and wheezing. Hypersensitivity to levothyroxine itself is not known to occur. Drug Interactions: Many drugs and some foods can exert effects on thyroid hormone pharmacokinetics (e.g., absorption, synthesis, secretion, catabolism, protein binding, and target tissue response) and may alter the therapeutic response to Levothyroxine sodium capsules. Administer at least 4 hours before or after drugs that are known to interfere with absorption. See full prescribing information for drugs that affect thyroid hormone pharmacokinetics and metabolism. To report SUSPECTED ADVERSE REACTIONS, contact Yaral Pharma Inc. at 1-866-218-9009, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. For Full Prescribing Information, including Boxed Warning, go to www.yaralpharma.com/levothyroxine-pi.

In part one of our special three-part series, join host Todd Eury as he takes you inside the 2025 FrameworkLTC Innovation Conference. Recorded live on-site, this episode features conversations with long-term care (LTC) pharmacy leaders, partner exhibitors, and members of the SoftWriters team. Hear firsthand insights and success stories that highlight innovation, collaboration, and the future of LTC pharmacy.

In this episode of The Executive Dose, host Stephen Beckman, CEO of YARAL Pharma, sits down with Tom Napolitano, Senior Vice President and General Manager of Real Value Rx. With more than 30 years of experience across distribution, purchasing, and pharmaceutical operations, Tom brings unmatched perspective on how strategy, partnerships, and execution define success in the pharmacy supply chain. Guest Spotlight – Tom Napolitano Current Role: SVP & General Manager, Real Value Rx – overseeing nationwide sales, purchasing, and operations. Previous Leadership: Chief Operating Officer at Praxis Med, driving national partnerships with retailers and suppliers. Industry Roots: Over two decades at Cardinal Health in senior roles across purchasing, distribution, and pricing innovation. Key Themes in This Episode How distribution partnerships shape the economics and stability of the pharmacy industry. The balance between generic and brand purchasing strategies for long-term growth. The evolving role of technology and data in supply chain decision-making. Lessons from Tom on drug shortages, preparation, and aligning with flexible organizations in drug wholesale.  Why collaboration between distributors, manufacturers, and pharmacies is critical to serving patients effectively. Why Listen This conversation provides rare insights into the strategic decisions that drive pharmacy distribution and supply chain resilience. Whether you’re a pharmacy executive, supplier, or healthcare innovator, Tom Napolitano’s perspective offers practical lessons on partnership, scale, and operational excellence.